scPharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
36.24 |
74.42 |
129.39 |
200.21 |
257.81 |
295.58 |
| Przychód Δ r/r |
0.00% |
105.37% |
73.86% |
54.73% |
28.77% |
14.65% |
| Przychód (min) |
36.05 |
67.45 |
113.06 |
180.93 |
232.97 |
267.11 |
| Przychód (max) |
36.50 |
86.22 |
150.01 |
227.68 |
293.18 |
336.13 |
| EBITDA (średnia) |
7.25 |
14.88 |
25.88 |
40.04 |
51.56 |
59.12 |
| EBIT (średnia) |
7.25 |
14.88 |
25.88 |
40.04 |
51.56 |
59.12 |
| EBIT % |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
| Zysk netto (średni) |
-84.51 |
-45.05 |
-15.39 |
33.75 |
60.32 |
79.69 |
| Zysk netto % |
-233.21% |
-60.54% |
-11.90% |
16.86% |
23.40% |
26.96% |
| EPS (średnia) |
-1.87 |
-1.01 |
-0.29 |
0.60 |
1.35 |
1.79 |
| Liczba analityków (Przychody) |
4 |
4 |
5 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
4 |
4 |
5 |
4 |
3 |
2 |
| symbol |
SCPH |
SCPH |
SCPH |
SCPH |
SCPH |
SCPH |